IL17A and myeloid sarcoma: Moreover, various cytokines, such as IL-17 and GM-CSF, can interact and worsen neuronal alterations during disease exacerbations, highlighting the complexity of the neuroinflammatory processes in MS (Amoriello et al., 2024).